Successful Management of Kratom Use Disorder With Buprenorphine and Naloxone

被引:2
|
作者
Arhin, Martin [1 ]
Mobley, Julian [1 ]
Hamad, Hamad [2 ]
Remick, Paul [2 ]
机构
[1] Univ North Carolina Chapel Hill, Sch Med, Chapel Hill, NC 27599 USA
[2] Geisinger Commonwealth Sch Med, Family Med, Scranton, PA USA
关键词
opioid use; methadone clinic; buprenorphine and naloxone; opioid taper; kratom addiction;
D O I
10.7759/cureus.41146
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Kratom is an unregulated herbal supplement that is growing in popularity in the United States. Its primary active ingredients, mitragynine, and 7-hydroxymitragynine, are partial agonists that act on mu-and delta-opioid receptors in the central nervous system, producing analgesia and a sense of euphoria. Kratom use can lead to addiction and adverse side effects, such as seizures, hallucinations, and coma. This case report presents a male in his 40s with a history of kratom use, who presented to the clinic seeking help for his addiction. The patient had been using kratom for several years to self-medicate for his anxiety and depression and gradually developed a kratom addiction. The patient was successfully treated with buprenorphine/naloxone, which helped alleviate his withdrawal symptoms and allowed him to abstain from kratom. This case underscores the growing issue of kratom addiction in the United States and the critical need for physician awareness in treating withdrawal.
引用
收藏
页数:4
相关论文
共 50 条
  • [21] The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
    Hansen, Brenna
    Inch, Katelyn M.
    Kaschor, Brenna A.
    BORDERLINE PERSONALITY DISORDER AND EMOTION DYSREGULATION, 2022, 9 (01)
  • [22] MULTIDISCIPLINARY SUPPORT FOR BUPRENORPHINE-NALOXONE TREATMENT OF OPIOID USE DISORDER
    Hall, A.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2020, 68 : A75 - A75
  • [23] Reasons for Buprenorphine/Naloxone Discontinuation in Veterans with Opioid Use Disorder and Pain
    Maxwell, Andrea
    Braxton, Alyssa
    Hartwell, Karen
    Tomko, Rachel
    AMERICAN JOURNAL ON ADDICTIONS, 2017, 26 (03): : 267 - 268
  • [24] The use of buprenorphine/naloxone to treat borderline personality disorder: a case report
    Brenna Hansen
    Katelyn M. Inch
    Brenna A. Kaschor
    Borderline Personality Disorder and Emotion Dysregulation, 9
  • [25] Prevalence of Kratom Use Disorder Among Kratom Consumers
    Hill, Katherine
    Grundmann, Oliver
    Smith, Kirsten E.
    Stanciu, Corneliu N.
    JOURNAL OF ADDICTION MEDICINE, 2024, 18 (03) : 306 - 312
  • [26] Patterns of Buprenorphine-Naloxone Treatment for Opioid Use Disorder in a Multistate Population
    Saloner, Brendan
    Daubresse, Matthew
    Alexander, G. Caleb
    MEDICAL CARE, 2017, 55 (07) : 669 - 676
  • [27] Treatment of Kratom Withdrawal and Dependence With Buprenorphine/Naloxone: A Case Series and Systematic Literature Review
    Weiss, Stephanie T.
    Douglas, Heather E.
    JOURNAL OF ADDICTION MEDICINE, 2021, 15 (02) : 167 - 172
  • [28] Buprenorphine-Naloxone Treatment of Kratom Addiction: A Unique Case Report and Literature Review
    Bath, Mandeep
    Chen, Andrew
    Shilpakar, Sona
    Surdhar, Amarjot
    AMERICAN JOURNAL ON ADDICTIONS, 2019, 28 (03): : 179 - 180
  • [29] Successful use of buprenorphine/naloxone to treat opioid addiction after cancer therapy.
    Moryl, Natalie
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (07)
  • [30] Kratom use disorder as a gateway to an opioid use disorder
    Borges, A. C.
    Machado, D.
    EUROPEAN PSYCHIATRY, 2023, 66 : S657 - S657